TREM2 and Alzheimer disease: Functional TREM2 expression is downregulated in some cases of late-onset AD and may exacerbate intestinal microbial metabolites’ endotoxin-induced pro-inflammatory responses (Zhong et al., 2015), causing defective antibody clearance (Xiang et al., 2016).